Fenticonazole nitrate
Gynoxin Optima and Gynoxin are different trade names for the same medicine.
This medicine should always be used exactly as described in the patient leaflet or according to the doctor's or pharmacist's instructions.
Gynoxin Optima contains the active substance fenticonazole, which is an imidazole derivative with a broad spectrum of antifungal activity, including against yeast. Fenticonazole also has antibacterial activity against Gram-positive and Gram-negative bacteria.
Indications for use
Vaginal yeast infections (vulvovaginitis, vaginitis, leukorrhea).
Treatment of mixed vaginal infections.
Gynoxin Optima is intended for use in adults and adolescents over 16 years of age.
Patients over 60 years of age should consult their doctor before using the medicine.
Gynoxin Optima is intended for topical use only.
A reliable diagnosis of fungal infection and determination of the microorganism's sensitivity to fenticonazole can only be made by a doctor. The information in section 2 of the leaflet should be read to determine when to consult a doctor before using the medicine.
The use of Gynoxin Optima should be discussed with a doctor or pharmacist if:
Eye contact with the medicine should be avoided.
If the partner is also infected, their simultaneous treatment is recommended.
Gynoxin Optima is not intended for use in children and adolescents under 16 years of age.
Gynoxin Optima contains fats and oils that can damage latex contraceptives (condoms, diaphragms) (see "Warnings and precautions").
It is not recommended to use spermicides at the same time. Any local vaginal treatment can inactivate spermicides used locally.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor before using this medicine. Gynoxin Optima should be used under medical supervision during pregnancy and breastfeeding. The applicator should not be used during pregnancy.
Gynoxin Optima has no effect on the ability to drive and use machines.
This medicine should always be used exactly as described in the patient leaflet or according to the doctor's instructions. In case of doubt, the doctor should be consulted.
Insert the contents of the applicator (about 5 g) deeply into the vagina. The cream should be used with the applicator (which can be washed and used multiple times). Apply once a day, in the evening before bedtime, for 6 consecutive days, or twice a day, in the evening before bedtime and in the morning, for 3 consecutive days.
Children and adolescents
The recommended dose for adolescents over 16 years of age is the same as for adults.
Use only a clean applicator. After each use, wash the applicator with warm water and soap.
The doctor may recommend sterilizing the applicator in exceptional cases.
Do not use water above 50°C or organic solvents.
After washing, dry the applicator and store it in the provided container.
Follow the instructions below (see also the diagram below).
In appropriate cases, it is possible to use the cream on the sexual partner (see "Warnings and precautions" in section 2).
In case of ingestion of the vaginal cream, the patient should immediately contact their doctor or go to the nearest hospital.
A double dose should not be used to make up for a missed dose.
In case of further doubts about the use of this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Gynoxin Optima can cause side effects, although not everybody gets them.
After inserting the cream into the vagina, a mild, transient burning sensation may occur.
If Gynoxin Optima is used according to the instructions, the active substance is poorly absorbed, and the occurrence of systemic side effects is unlikely.
Topical medicines, especially when used for a long time, can cause hypersensitivity (see "Warnings and precautions" in section 2).
The following side effects have been observed after using this medicine:
Very rare(less than 1 in 10,000):
Unknown(frequency cannot be estimated from the available data):
If side effects occur, including any side effects not listed in the leaflet, the patient should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Pharmacovigilance of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Reporting side effects can help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
There are no special storage instructions.
The medicine should not be used after the expiry date stated on the packaging. The expiry date refers to the last day of the specified month.
Medicines should not be disposed of via wastewater or household waste. The pharmacist should be asked how to dispose of unused medicines. This will help protect the environment.
Tube in a cardboard box. The package contains 35 g of cream in a tube and 7 applicators (for single use).
For more detailed information, the marketing authorization holder or parallel importer should be contacted.
Recordati Industria Chimica e Farmaceutica S.p.A.
Via Matteo Civitali 1, 20148 Milan, Italy
Recordati Industria Chimica e Farmaceutica S.p.A.
Via Matteo Civitali 1, 20148 Milan, Italy
Vamfarma S.R.L.
Via Kennedy, 5, 26833 Comazzo (Lodi), Italy
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Belgian marketing authorization number, in the country of export: BE162504
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.